SCIMEDX PHASE II MPO IGG ANTIBODY EIA (1281)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II MPO IGG ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-myeloperoxidase (MPO) antibodies (K010289 | K010289) HIGH
Effective Date: 2001-03-28

Other General Immunology Devices:

Medical DeviceComplexity
Siemens ADVIA 2400View Complexity
Roche Diagnostics Hitachi 717View Complexity
Zeus Scientific Rheumatoid Factor (RF) IgM ELISAView Complexity
The Binding Site SPAplusView Complexity
Siemens ADVIA 1200View Complexity
Dade Behring Dimension Clinical Chemistry SystemView Complexity
Roche Diagnostics Hitachi 911 AnalyzerView Complexity
Siemens Dimension Vista Integrated SystemView Complexity
BIO-RAD LABORATORIES BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEMView Complexity
Meridian Diagnostics ImmunoCard H. pyloriView Complexity